Global Arginase Deficiency Drugs Market Growth (Status and Outlook) 2025-2031

September 2025 | 76 pages | ID: GEA4C228457EN
LP Information

Abstracts

According to this study, the global Arginase Deficiency Drugs market size will reach US$ 146 million by 2031.

Argininemia, also called arginase deficiency, is an autosomal recessive urea cycle disorder where adeficiency of the enzyme arginase causes a buildup of arginine and ammonia in the blood.

The Arginase deficiency drugs market is driven by the growing awareness and diagnosis of this rare genetic disorder. As understanding of the disease improves, more patients are being identified and seeking treatment options. The development of targeted therapies to address the underlying metabolic abnormalities associated with Arginase deficiency has also contributed to market growth. Additionally, government initiatives and orphan drug designations have facilitated research and development in this area. However, the market faces challenges like limited patient populations, high treatment costs, and the need for specialized medical expertise for diagnosis and management. Overcoming these challenges through increased awareness, early diagnosis, and affordable access to therapies will be essential for the sustained growth of the Arginase deficiency drugs market.

LPI (LP Information)' newest research report, the “Arginase Deficiency Drugs Industry Forecast” looks at past sales and reviews total world Arginase Deficiency Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Arginase Deficiency Drugs sales for 2025 through 2031. With Arginase Deficiency Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Arginase Deficiency Drugs industry.

This Insight Report provides a comprehensive analysis of the global Arginase Deficiency Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Arginase Deficiency Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Arginase Deficiency Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Arginase Deficiency Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Arginase Deficiency Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Arginase Deficiency Drugs market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Oral
• Injection

Segmentation by Application:

• Hospital
• Drugs Stores
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Helsinn Healthcare
• Novartis Pharmaceuticals
• Horizo??n Pharma
• Medicis Pharmaceutical

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Arginase Deficiency Drugs Market Size (2020-2031)
  2.1.2 Arginase Deficiency Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Arginase Deficiency Drugs by Country/Region (2020, 2024 & 2031)
2.2 Arginase Deficiency Drugs Segment by Type
  2.2.1 Oral
  2.2.2 Injection
2.3 Arginase Deficiency Drugs Market Size by Type
  2.3.1 Arginase Deficiency Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Arginase Deficiency Drugs Market Size Market Share by Type (2020-2025)
2.4 Arginase Deficiency Drugs Segment by Application
  2.4.1 Hospital
  2.4.2 Drugs Stores
  2.4.3 Other
2.5 Arginase Deficiency Drugs Market Size by Application
  2.5.1 Arginase Deficiency Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Arginase Deficiency Drugs Market Size Market Share by Application (2020-2025)

3 ARGINASE DEFICIENCY DRUGS MARKET SIZE BY PLAYER

3.1 Arginase Deficiency Drugs Market Size Market Share by Player
  3.1.1 Global Arginase Deficiency Drugs Revenue by Player (2020-2025)
  3.1.2 Global Arginase Deficiency Drugs Revenue Market Share by Player (2020-2025)
3.2 Global Arginase Deficiency Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ARGINASE DEFICIENCY DRUGS BY REGION

4.1 Arginase Deficiency Drugs Market Size by Region (2020-2025)
4.2 Global Arginase Deficiency Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Arginase Deficiency Drugs Market Size Growth (2020-2025)
4.4 APAC Arginase Deficiency Drugs Market Size Growth (2020-2025)
4.5 Europe Arginase Deficiency Drugs Market Size Growth (2020-2025)
4.6 Middle East & Africa Arginase Deficiency Drugs Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Arginase Deficiency Drugs Market Size by Country (2020-2025)
5.2 Americas Arginase Deficiency Drugs Market Size by Type (2020-2025)
5.3 Americas Arginase Deficiency Drugs Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Arginase Deficiency Drugs Market Size by Region (2020-2025)
6.2 APAC Arginase Deficiency Drugs Market Size by Type (2020-2025)
6.3 APAC Arginase Deficiency Drugs Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Arginase Deficiency Drugs Market Size by Country (2020-2025)
7.2 Europe Arginase Deficiency Drugs Market Size by Type (2020-2025)
7.3 Europe Arginase Deficiency Drugs Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Arginase Deficiency Drugs by Region (2020-2025)
8.2 Middle East & Africa Arginase Deficiency Drugs Market Size by Type (2020-2025)
8.3 Middle East & Africa Arginase Deficiency Drugs Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ARGINASE DEFICIENCY DRUGS MARKET FORECAST

10.1 Global Arginase Deficiency Drugs Forecast by Region (2026-2031)
  10.1.1 Global Arginase Deficiency Drugs Forecast by Region (2026-2031)
  10.1.2 Americas Arginase Deficiency Drugs Forecast
  10.1.3 APAC Arginase Deficiency Drugs Forecast
  10.1.4 Europe Arginase Deficiency Drugs Forecast
  10.1.5 Middle East & Africa Arginase Deficiency Drugs Forecast
10.2 Americas Arginase Deficiency Drugs Forecast by Country (2026-2031)
  10.2.1 United States Market Arginase Deficiency Drugs Forecast
  10.2.2 Canada Market Arginase Deficiency Drugs Forecast
  10.2.3 Mexico Market Arginase Deficiency Drugs Forecast
  10.2.4 Brazil Market Arginase Deficiency Drugs Forecast
10.3 APAC Arginase Deficiency Drugs Forecast by Region (2026-2031)
  10.3.1 China Arginase Deficiency Drugs Market Forecast
  10.3.2 Japan Market Arginase Deficiency Drugs Forecast
  10.3.3 Korea Market Arginase Deficiency Drugs Forecast
  10.3.4 Southeast Asia Market Arginase Deficiency Drugs Forecast
  10.3.5 India Market Arginase Deficiency Drugs Forecast
  10.3.6 Australia Market Arginase Deficiency Drugs Forecast
10.4 Europe Arginase Deficiency Drugs Forecast by Country (2026-2031)
  10.4.1 Germany Market Arginase Deficiency Drugs Forecast
  10.4.2 France Market Arginase Deficiency Drugs Forecast
  10.4.3 UK Market Arginase Deficiency Drugs Forecast
  10.4.4 Italy Market Arginase Deficiency Drugs Forecast
  10.4.5 Russia Market Arginase Deficiency Drugs Forecast
10.5 Middle East & Africa Arginase Deficiency Drugs Forecast by Region (2026-2031)
  10.5.1 Egypt Market Arginase Deficiency Drugs Forecast
  10.5.2 South Africa Market Arginase Deficiency Drugs Forecast
  10.5.3 Israel Market Arginase Deficiency Drugs Forecast
  10.5.4 Turkey Market Arginase Deficiency Drugs Forecast
10.6 Global Arginase Deficiency Drugs Forecast by Type (2026-2031)
10.7 Global Arginase Deficiency Drugs Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Arginase Deficiency Drugs Forecast

11 KEY PLAYERS ANALYSIS

11.1 Helsinn Healthcare
  11.1.1 Helsinn Healthcare Company Information
  11.1.2 Helsinn Healthcare Arginase Deficiency Drugs Product Offered
  11.1.3 Helsinn Healthcare Arginase Deficiency Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Helsinn Healthcare Main Business Overview
  11.1.5 Helsinn Healthcare Latest Developments
11.2 Novartis Pharmaceuticals
  11.2.1 Novartis Pharmaceuticals Company Information
  11.2.2 Novartis Pharmaceuticals Arginase Deficiency Drugs Product Offered
  11.2.3 Novartis Pharmaceuticals Arginase Deficiency Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Novartis Pharmaceuticals Main Business Overview
  11.2.5 Novartis Pharmaceuticals Latest Developments
11.3 Horizo??n Pharma
  11.3.1 Horizo??n Pharma Company Information
  11.3.2 Horizo??n Pharma Arginase Deficiency Drugs Product Offered
  11.3.3 Horizo??n Pharma Arginase Deficiency Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Horizo??n Pharma Main Business Overview
  11.3.5 Horizo??n Pharma Latest Developments
11.4 Medicis Pharmaceutical
  11.4.1 Medicis Pharmaceutical Company Information
  11.4.2 Medicis Pharmaceutical Arginase Deficiency Drugs Product Offered
  11.4.3 Medicis Pharmaceutical Arginase Deficiency Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Medicis Pharmaceutical Main Business Overview
  11.4.5 Medicis Pharmaceutical Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Arginase Deficiency Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Arginase Deficiency Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injection
Table 5. Arginase Deficiency Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Arginase Deficiency Drugs Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Arginase Deficiency Drugs Market Size Market Share by Type (2020-2025)
Table 8. Arginase Deficiency Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Arginase Deficiency Drugs Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Arginase Deficiency Drugs Market Size Market Share by Application (2020-2025)
Table 11. Global Arginase Deficiency Drugs Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Arginase Deficiency Drugs Revenue Market Share by Player (2020-2025)
Table 13. Arginase Deficiency Drugs Key Players Head office and Products Offered
Table 14. Arginase Deficiency Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Arginase Deficiency Drugs Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Arginase Deficiency Drugs Market Size Market Share by Region (2020-2025)
Table 19. Global Arginase Deficiency Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Arginase Deficiency Drugs Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Arginase Deficiency Drugs Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Arginase Deficiency Drugs Market Size Market Share by Country (2020-2025)
Table 23. Americas Arginase Deficiency Drugs Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Arginase Deficiency Drugs Market Size Market Share by Type (2020-2025)
Table 25. Americas Arginase Deficiency Drugs Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Arginase Deficiency Drugs Market Size Market Share by Application (2020-2025)
Table 27. APAC Arginase Deficiency Drugs Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Arginase Deficiency Drugs Market Size Market Share by Region (2020-2025)
Table 29. APAC Arginase Deficiency Drugs Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Arginase Deficiency Drugs Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Arginase Deficiency Drugs Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Arginase Deficiency Drugs Market Size Market Share by Country (2020-2025)
Table 33. Europe Arginase Deficiency Drugs Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Arginase Deficiency Drugs Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Arginase Deficiency Drugs Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Arginase Deficiency Drugs Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Arginase Deficiency Drugs Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Arginase Deficiency Drugs
Table 39. Key Market Challenges & Risks of Arginase Deficiency Drugs
Table 40. Key Industry Trends of Arginase Deficiency Drugs
Table 41. Global Arginase Deficiency Drugs Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Arginase Deficiency Drugs Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Arginase Deficiency Drugs Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Arginase Deficiency Drugs Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Helsinn Healthcare Details, Company Type, Arginase Deficiency Drugs Area Served and Its Competitors
Table 46. Helsinn Healthcare Arginase Deficiency Drugs Product Offered
Table 47. Helsinn Healthcare Arginase Deficiency Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Helsinn Healthcare Main Business
Table 49. Helsinn Healthcare Latest Developments
Table 50. Novartis Pharmaceuticals Details, Company Type, Arginase Deficiency Drugs Area Served and Its Competitors
Table 51. Novartis Pharmaceuticals Arginase Deficiency Drugs Product Offered
Table 52. Novartis Pharmaceuticals Arginase Deficiency Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Novartis Pharmaceuticals Main Business
Table 54. Novartis Pharmaceuticals Latest Developments
Table 55. Horizo??n Pharma Details, Company Type, Arginase Deficiency Drugs Area Served and Its Competitors
Table 56. Horizo??n Pharma Arginase Deficiency Drugs Product Offered
Table 57. Horizo??n Pharma Arginase Deficiency Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Horizo??n Pharma Main Business
Table 59. Horizo??n Pharma Latest Developments
Table 60. Medicis Pharmaceutical Details, Company Type, Arginase Deficiency Drugs Area Served and Its Competitors
Table 61. Medicis Pharmaceutical Arginase Deficiency Drugs Product Offered
Table 62. Medicis Pharmaceutical Arginase Deficiency Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Medicis Pharmaceutical Main Business
Table 64. Medicis Pharmaceutical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Arginase Deficiency Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Arginase Deficiency Drugs Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Arginase Deficiency Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Arginase Deficiency Drugs Sales Market Share by Country/Region (2024)
Figure 8. Arginase Deficiency Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Arginase Deficiency Drugs Market Size Market Share by Type in 2024
Figure 10. Arginase Deficiency Drugs in Hospital
Figure 11. Global Arginase Deficiency Drugs Market: Hospital (2020-2025) & ($ millions)
Figure 12. Arginase Deficiency Drugs in Drugs Stores
Figure 13. Global Arginase Deficiency Drugs Market: Drugs Stores (2020-2025) & ($ millions)
Figure 14. Arginase Deficiency Drugs in Other
Figure 15. Global Arginase Deficiency Drugs Market: Other (2020-2025) & ($ millions)
Figure 16. Global Arginase Deficiency Drugs Market Size Market Share by Application in 2024
Figure 17. Global Arginase Deficiency Drugs Revenue Market Share by Player in 2024
Figure 18. Global Arginase Deficiency Drugs Market Size Market Share by Region (2020-2025)
Figure 19. Americas Arginase Deficiency Drugs Market Size 2020-2025 ($ millions)
Figure 20. APAC Arginase Deficiency Drugs Market Size 2020-2025 ($ millions)
Figure 21. Europe Arginase Deficiency Drugs Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Arginase Deficiency Drugs Market Size 2020-2025 ($ millions)
Figure 23. Americas Arginase Deficiency Drugs Value Market Share by Country in 2024
Figure 24. United States Arginase Deficiency Drugs Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Arginase Deficiency Drugs Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Arginase Deficiency Drugs Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Arginase Deficiency Drugs Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Arginase Deficiency Drugs Market Size Market Share by Region in 2024
Figure 29. APAC Arginase Deficiency Drugs Market Size Market Share by Type (2020-2025)
Figure 30. APAC Arginase Deficiency Drugs Market Size Market Share by Application (2020-2025)
Figure 31. China Arginase Deficiency Drugs Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Arginase Deficiency Drugs Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Arginase Deficiency Drugs Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Arginase Deficiency Drugs Market Size Growth 2020-2025 ($ millions)
Figure 35. India Arginase Deficiency Drugs Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Arginase Deficiency Drugs Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Arginase Deficiency Drugs Market Size Market Share by Country in 2024
Figure 38. Europe Arginase Deficiency Drugs Market Size Market Share by Type (2020-2025)
Figure 39. Europe Arginase Deficiency Drugs Market Size Market Share by Application (2020-2025)
Figure 40. Germany Arginase Deficiency Drugs Market Size Growth 2020-2025 ($ millions)
Figure 41. France Arginase Deficiency Drugs Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Arginase Deficiency Drugs Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Arginase Deficiency Drugs Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Arginase Deficiency Drugs Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Arginase Deficiency Drugs Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Arginase Deficiency Drugs Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Arginase Deficiency Drugs Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Arginase Deficiency Drugs Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Arginase Deficiency Drugs Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Arginase Deficiency Drugs Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Arginase Deficiency Drugs Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Arginase Deficiency Drugs Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Arginase Deficiency Drugs Market Size 2026-2031 ($ millions)
Figure 54. APAC Arginase Deficiency Drugs Market Size 2026-2031 ($ millions)
Figure 55. Europe Arginase Deficiency Drugs Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Arginase Deficiency Drugs Market Size 2026-2031 ($ millions)
Figure 57. United States Arginase Deficiency Drugs Market Size 2026-2031 ($ millions)
Figure 58. Canada Arginase Deficiency Drugs Market Size 2026-2031 ($ millions)
Figure 59. Mexico Arginase Deficiency Drugs Market Size 2026-2031 ($ millions)
Figure 60. Brazil Arginase Deficiency Drugs Market Size 2026-2031 ($ millions)
Figure 61. China Arginase Deficiency Drugs Market Size 2026-2031 ($ millions)
Figure 62. Japan Arginase Deficiency Drugs Market Size 2026-2031 ($ millions)
Figure 63. Korea Arginase Deficiency Drugs Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Arginase Deficiency Drugs Market Size 2026-2031 ($ millions)
Figure 65. India Arginase Deficiency Drugs Market Size 2026-2031 ($ millions)
Figure 66. Australia Arginase Deficiency Drugs Market Size 2026-2031 ($ millions)
Figure 67. Germany Arginase Deficiency Drugs Market Size 2026-2031 ($ millions)
Figure 68. France Arginase Deficiency Drugs Market Size 2026-2031 ($ millions)
Figure 69. UK Arginase Deficiency Drugs Market Size 2026-2031 ($ millions)
Figure 70. Italy Arginase Deficiency Drugs Market Size 2026-2031 ($ millions)
Figure 71. Russia Arginase Deficiency Drugs Market Size 2026-2031 ($ millions)
Figure 72. Egypt Arginase Deficiency Drugs Market Size 2026-2031 ($ millions)
Figure 73. South Africa Arginase Deficiency Drugs Market Size 2026-2031 ($ millions)
Figure 74. Israel Arginase Deficiency Drugs Market Size 2026-2031 ($ millions)
Figure 75. Turkey Arginase Deficiency Drugs Market Size 2026-2031 ($ millions)
Figure 76. Global Arginase Deficiency Drugs Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Arginase Deficiency Drugs Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Arginase Deficiency Drugs Market Size 2026-2031 ($ millions)